Supriya Munshaw is a Senior Lecturer in the Practice Track. Her primary interest lies in commercialization of early-stage technologies especially in the life science and medical device industries. At Carey she has taught several courses including Discovery to Market, Pharmaceutical Strategy, Statistical Analysis, Business Leadership and Human Values and, New Product Development. She is one of the founders and organizers of the Johns Hopkins Bootcamp for Biomedical Entrepreneurs. She serves as the Chair of the Committee on Diversity and Inclusion for faculty and staff at Carey. Outside of Carey, she is very involved in the entrepreneurial ecosystem in Baltimore by investing in and advising local tech, biotech and medtech startups. Additionally, she has served as adjunct faculty for the NSF I-corps program and on several NIH SBIR grant review panels.
- Ph. D, Computational Biology and Bioinformatics, Duke University
- BA, Biology, Bard College
- Munshaw, S. & Chawla, A., (2019). Pricing a new drug. In SAGE Business Cases.
- Munshaw, S., Lee, S. H., Phan, P., & Marr, K. (Accepted/In press). The influence of human capital and perceived university support on patent applications of biomedical investigators. Journal of Technology Transfer, 1-20.
- Wasilewski L, El-Diwany R, Munshaw S, Snider A, Brady J, Osburn W.O., Ray S.C, and Bailey J.R. (2016). A hepatitis C virus envelope polymorphism confers resistance to neutralization by polyclonal sera and broadly neutralizing monoclonal antibodies. J Virol. 90(7): 3773-82.
- Kepler T.B., Munshaw S, Wiehe K., Zhang R., Yu J.S., Woods C.W., Denny T.N., Tomaras G.D., Alam S.M., Moody M.A., Kelsoe G., Liao H.X., Haynes B.F. (2014). Reconstructing a B-Cell Clonal Lineage. II. Mutation, Selection, and Affinity Maturation. Front Immunol. Apr 22;5:170.
- Grabowski, M. K., Lessler, J., Redd, A. D., Kagaayi, J., Laeyendecker, O., Ndyanabo, A., Nelson, M. I., Cummings, D. A., Bwanika, J. B., Mueller, A. C., Reynolds, S. J., Munshaw, S., Ray, S. C., Lutalo, T., Manucci, J., Tobian, A. A., Chang, L. W., Beyrer, C., Jennings, J. M., Nalugoda, F., Serwadda, D., Wawer, M. J., Quinn, T. C., Gray, R. H. (2014). The Role of Viral Introductions in Sustaining Community-Based HIV Epidemics in Rural Uganda: Evidence from Spatial Clustering, Phylogenetics, and Egocentric Transmission Models.. PLoS medicine, 11(3), e1001610.
- Ng, O. T., Laeyendecker, O., Redd, A. D., Munshaw, S., Grabowski, M. K., Paquet, A. C., Evans, M. C., Haddad, M., Huang, W., Robb, M. L., Reynolds, S. J., Gray, R. H., Wawer, M. J., Serwadda, D., Eshleman, S. H., Quinn, T. C. (2014). HIV type 1 polymerase gene polymorphisms are associated with phenotypic differences in replication capacity and disease progression.. The Journal of infectious diseases, 209(1), 66-73.
- Mullis, C. E., Munshaw, S., Grabowski, M. K., Eshleman, S. H., Serwadda, D., Brookmeyer, R., Nalugoda, F., Kigozi, G., Kagaayi, J., Tobian, A. A., Wawer, M., Gray, R. H., Quinn, T. C., Laeyendecker, O. (2013). Differential specificity of HIV incidence assays in HIV subtypes A and D-infected individuals from Rakai, Uganda.. AIDS research and human retroviruses, 29(8), 1146-50.
- Bailey, J. R., Laskey, S., Wasilewski, L. N., Munshaw, S., Fanning, L. J., Kenny-Walsh, E., Ray, S. C. (2012). Constraints on viral evolution during chronic hepatitis C virus infection arising from a common-source exposure. Journal of virology, 86(23), 12582-90.
- Reimbursement in the Era of $2million therapies
- Pharmaceutical Strategy
- Discovery to Market I & II
- Biotechnology and Pharmaceuticals
- Statistical Analysis
Honors and distinctions
- Dean's Award for Faculty Excellence, Johns Hopkins Carey Business School, 2018, 2019
- Diversity Recognition Award, Johns Hopkins University, 2019
Impact and engagement
- Investment Partner, TCP Venture Capital, Baltimore, MD